Ï㽶ÊÓƵ

Brain Tumour Research Group

Areas of research include, but are not limited to, uncovering fundamental regulatory mechanisms that govern brain cancer development, regulate brain cancer stem-cell self-renewal and differentiation, drive invasion, and lead to treatment resistance. All state-of-the-art technologies are available including next-generation genomic and epigenomic testing, computational biology approaches, cell-based assays for drug screening, patient-derived cranial xenograft modeling, and small animal imaging.

Group Leader
Kevin Petrecca

Rolando Fausto Del Maestro, MD, PhD

Rolando Fausto Del Maestro, MD, PhD

Research areas: Brain Tumour
Roberto Diaz, MD, PhD, FRCS(C)

Roberto Diaz, MD, PhD, FRCS(C)

Research areas: Brain Tumour
Jerome Fortin, PhD

Jerome Fortin, PhD

Research areas: Brain Tumour

Marie Christine Guiot, MD

Research areas: Brain Tumour
Richard Leblanc, MD

Richard Leblanc, MD

Research areas: Brain Tumour
Kevin Petrecca, MD, PhD, FRCS(C)

Kevin Petrecca, MD, PhD, FRCS(C)

Research areas: Brain Tumour
Stefano Stifani, PhD

Stefano Stifani, PhD

Research areas: Brain Tumour, Neurodegenerative Disorders, Neurodevelopmental Disorders

Media Enquiries:

Shawn Hayward
Communications Officer
514-893-3376
shawn.hayward [at] mcgill.ca (subject: Media%20Enquiry%20from%20The%20Neuro%20website)

The Neuro logoÌýMcGill logo

Ìý

The Neuro (Montreal Neurological Institute-Hospital)Ìýis a bilingual academic healthcare institution. We are aÌýMcGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the Ï㽶ÊÓƵ Health Centre.ÌýWe areÌýproud to be a Killam Institution, supported by the Killam Trusts.

Ìý

Ìý

Back to top